416 results about "Nerves tissue" patented technology

According to one aspect, an electrical stimulation system provides reduced neuroplasticity effects in a person's nerve tissue. The system includes an electrical stimulation lead adapted for implantation into the person's body for electrical stimulation of target nerve tissue. The lead includes a number of electrodes adapted to be positioned near the target nerve tissue and to deliver electrical stimulation energy to the target nerve tissue. The system also includes a stimulation source connectable to the lead and operable to generate signals for transmission to the electrodes of the lead to cause the electrodes to deliver electrical stimulation energy to the target nerve tissue to reduce neuroplasticity effects.

An electrosurgical system preferably used for denervation procedures of nerve tissue has a control unit and a pluggable electrode assembly. The electrode assembly has a preferably disposable cannula and a preservable supply electrode assembly. The cannula has a tubular body that projects axially from a preferably pointed distal end for piercing tissue to a proximal end engaged to a first coupling assembly of the cannula. The body carries a first contact exposed directly to the nerve tissue and connected electrically to a terminal of the first coupling assembly. The supply electrode assembly has a second coupling assembly and a supply electrode that projects axially and removably into a through-bore of the body when the tool is in an operating state. The second coupling assembly carries a terminal that abuts the first coupling assembly when the coupling assemblies are mated. Preferably the supply electrode carries a temperature sensor for temperature measurement of the targeted tissue and processing by the control unit. Preferably, the electrode assembly also includes a stylet having a rod that fits into the through-bore of the body when the supply electrode assembly is removed and the tool is in a tissue penetrating state.

A probe and method for removing tissue is provided. The probe comprises an elongated member, a window laterally formed on the distal end of the member, a drive shaft rotatably disposed within the lumen of the member, and a rotatable and longitudinally slidable tissue removal element disposed on the drive shaft. The probe can be used to remove tissue along the window of the probe. In one method, target tissue along the window, e.g., bone tissue, can be removed without removing non-target tissue, e.g., nerve tissue, by rotating and longitudinally sliding the tissue removal element relative to the window.

An apparatus and method for stimulating animal tissue (for example to trigger a nerve action potential (NAP) signal in a human patient) by application of both electrical and optical signals for treatment and diagnosis purposes. The application of an electrical signal before or simultaneously to the application of a NAP-triggering optical signal allows the use of a lower amount of optical power or energy than would otherwise be needed if an optical signal alone was used for the same purpose and effectiveness. The application of the electrical signal may precondition the nerve tissue such that a lower-power optical signal can be used to trigger the desired NAP, which otherwise would take a higher-power optical signal were the electric signal not applied. Some embodiments include an implanted nerve interface having a plurality of closely spaced electrodes placed transversely and/or longitudinally to the nerve and a plurality of optical emitters.

A process for stimulating tissue such as cardiac tissue, nerve tissue, and brain tissue. In one step of the process, there is delivered an electrical stimulating signal to the tissue that contains from about 10 to about 1,000 individual pulses. Each individual pulse has a duration of from about one microsecond to about 100 microseconds and is discontinuous, with a spacing between adjacent pulses of at least from about 1 microsecond to about 100 microseconds. The individual pulses have a voltage of from about 10 millivolts to about 100 volts.

A method and system for discriminating tissues in a subject, particularly for identifying nerve tissue, includes a processor, a waveform generator, a waveform electrode and a return electrode and an electrical property measuring device such as a volt meter. The electrodes are applied to the skin of the subject and an electrical waveform applied to the tissue via the electrodes. A series of electrical property measurements between the electrodes yield digital data that is used to determine coefficients of an approximating mathematical function, which is then used to derived electrical properties of the tissue. Derived electrical properties are then displayed on a display device.

Devices, systems and methods are provided for simultaneously stimulating the spinal anatomy at various locations, such as spinal levels, along the spinal cord. By stimulating multiple levels of the spinal column with the use of a single device, a single access path is created to an implantable pulse generator (IPG) rather than individual access paths for each lead at each spinal level to an IPG. By reducing the number of pathways, the procedure complexity, time and recovery are reduced. In addition, some embodiments provide additional specificity within each targeted level, such as selective stimulation of specific tissue, such as the dorsal root ganglion.

A system and method can be used to denervate at least a portion of a bronchial tree. An energy emitter of an instrument is percutaneously delivered to a treatment site and outputs energy to damage nerve tissue of the bronchial tree. The denervation procedure can be performed without damaging non-targeted tissue. Minimally invasive methods can be used to open airways to improve lung function in subjects with COPD, asthma, or the like. Different sections of the bronchial tree can be denervated while leaving airways intact to reduce recovery times.

The present invention provides new methods for the in vitro preparation of bioartificial tissue equivalents and their enhanced integration after implantation in vivo. These methods include submitting a tissue construct to a biomimetic electrical stimulation during cultivation in vitro to improve its structural and functional properties, and/or in vivo, after implantation of the construct, to enhance its integration with host tissue and increase cell survival and functionality. The inventive methods are particularly useful for the production of bioartificial equivalents and/or the repair and replacement of native tissues that contain electrically excitable cells and are subject to electrical stimulation in vivo, such as, for example, cardiac muscle tissue, striated skeletal muscle tissue, smooth muscle tissue, bone, vasculature, and nerve tissue.

According to one embodiment, a neurological stimulation system is adapted for implantation into a person's body for electrical, chemical, or combined electrical and chemical stimulation of target nerve tissue in the person's brain stem. For electrical stimulation, the system includes an electrical stimulation lead adapted for implantation on, in, or near the brain stem, and including electrodes adapted to be positioned on, in, or near target nerve tissue in the brain stem, for delivering electrical stimulation energy to the target nerve tissue. For chemical stimulation, the system includes an infusion catheter adapted for implantation on, in, or near the brain stem, and including openings adapted to be positioned on, in, or near target nerve tissue in the brain stem, for delivering a chemical to the target nerve tissue. The system also includes a stimulation source adapted for implantation in the person's body and operable to generate pulses of electrical stimulation energy or pulses of the chemical, for delivery to the target nerve tissue in the brain stem.

This disclosure is directed to extra, intra, and transvascular medical lead placement techniques for arranging medical leads and electrical stimulation and/or sensing electrodes proximate nerve tissue within a patient.

A stimulation system includes a stimulation source, an implantable stimulation lead, an implantable sensing device, and a controller. The stimulation source generates and transmits stimulation pulses to stimulation electrodes on the stimulation lead. The stimulation electrodes deliver the stimulation pulses to target nerve tissue in a nerve pathway to cause paresthesia in a portion of the person's body. Each stimulation pulse induces an action potential in a number of nerve fibers in the nerve pathway. The sensing device includes sensing electrodes positioned proximate the nerve pathway that detect compound action potentials of nerve fibers stimulated by the stimulation pulses. The controller modifies the stimulation pulses generated by the stimulation source and delivered to the target nerve tissue by the stimulation electrodes based on the detected compound action potentials to maintain a substantially constant level of paresthesia in the portion of the person's body.

The method and system for non-invasively repositioning at least one stimulating electrode on a lead relative to tissue, such as nerve tissue, in a body includes elements for carrying out the method and the steps of: providing a lead having at least one stimulating electrode thereon which is located skew to an elongate axis of the lead; implanting the lead in a body; implanting in the body a drive mechanism having structure for engaging and rotating the lead; and, providing an exterior signal generating and transmitting mechanism for transmitting electromagnetic signals from outside the body to the drive mechanism implanted in the body for causing the drive mechanism to rotate the lead thereby to adjust the position of the at least one stimulating electrode on the lead relative to tissue in the body.

PCT No. PCT/JP97/04203 Sec. 371 Date May 20, 1999 Sec. 102(e) Date May 20, 1999 PCT Filed Nov. 19, 1997 PCT Pub. No. WO98/22155 PCT Pub. Date May 28, 1998The present invention offers an artificial tube for nerve which can remain in the body until the nerve regenerates while does not remain as a foreign body in the body following nerve regeneration, and which induces axons regenerated from severed nerve stumps, can promote infiltration of blood capillaries from the body and regeneration of nerve tissue. The present invention comprises a tube 10 or 20 having coating layers 12, 13 or 22, 23 composed of gelatin or collagen on the inner and outer surfaces of a tube 11 or 21 composed of a material being biodegradable and absorbable in vivo, and a collagen body 30 or 40 having cavities 32, 33 or 41 which pass through said tube so as to be substantially parallel to the axis of said tube; wherein, said cavities are filled with a matrix gel.

Apparatus (18) for treating a condition of a subject is provided. An electrode device (100) is adapted to be coupled to longitudinal nervous tissue (40) of the subject, and a control unit (50) is adapted to drive the electrode device to apply to the nervous tissue a current which is capable of inducing action potentials that propagate in the nervous tissue in a first direction, so as to treat the condition. The control unit is further adapted to suppress action potentials from propagating in the nervous tissue in a second direction opposite to the first direction.

Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input. The system, delivery devices, and methods can damage tissue and manage scarring and stenosis.

Substituted piperidine compounds represented by the structure I are provided,

wherein each of R_1a, R_1b, R_1c, R_1d, R_1e, R_1f, R_1g, R_1h, R₂, R_2A, R₃, R₄, A, X, a, x and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated. Pharmaceutical compositions containing these substituted piperidine compounds may be useful to promote neurite growth and in the treatment of diseases in which Rho kinase inhibition is indicated.

A probe and method for removing tissue is provided. The probe comprises an elongated member, a window laterally formed on the distal end of the member, a drive shaft rotatably disposed within the lumen of the member, and a rotatable tissue removal element disposed on the drive shaft. The tissue removal probe further comprises irrigation and aspiration lumens extending through the member in fluid communication with the window. In one method, target tissue, e.g., bone tissue, can be removed without removing non-target tissue, e.g., nerve tissue, by rotating the tissue removal element relative to the window. Fluid can be conveyed through the irrigation lumen into contact with the rotating tissue removal element. As a result of the rotation of the tissue removal element, the tissue is irrigated and removed, and forced towards the aspiration lumen. The irrigation fluid and removed tissue is then aspirated into the aspiration lumen.

A system and method for discriminating tissue types, controlling the level of therapy to tissue, and determining the health or a known tissue by measuring the characteristics an electrical signal applied to conductive element located within or by the tissue. Additionally, the system and method may be used for determining whether the conductive tip of a pedicle probe or pedicle screw is located in one of cortical bone, cancellous bone, and cortical bone near a boundary with soft tissue, whether the conductive tip of a cannula is located adjacent to one of nerve tissue and annulus tissue, and whether the conductive tip of a cathode is located adjacent to one of nerve tissue and prostate gland tissue.